Arrevus

• Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

  Phase 2, Terminated, 14 people, Dec 28, 2012

Sources: clinicaltrials.gov